Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — Wegovy (semaglutide) can produce meaningful weight loss without a formal exercise programme. In the pivotal STEP 1 trial, participants lost an average of around 15% of their body weight over 68 weeks alongside a reduced-calorie diet; structured exercise was not a requirement of the trial protocol. Wegovy is a prescription-only medicine, so a prescriber decides whether it is clinically appropriate for you after a thorough assessment. That said, the story doesn't end at "yes" — understanding what exercise actually changes, and what it doesn't, helps you get the most from treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: the plain DPD parcel arrives, you put the pen in the fridge, and you're already wondering whether you need to overhaul your whole routine to see results. The short answer is no. Semaglutide reduces appetite by acting on GLP-1 receptors in the brain and gut, slowing how quickly your stomach empties and signalling fullness sooner than you'd usually feel it. That biological shift happens regardless of whether you run three times a week or barely walk to the end of the road.
The STEP 1 trial, published in the New England Journal of Medicine, found an average body-weight reduction of around 15% over 68 weeks when semaglutide 2.4mg was combined with a reduced-calorie diet and lifestyle counselling. Participants were encouraged to be more active, but the trial did not require a structured exercise plan, and the weight-loss results reflect that mixed real-world picture. So if you're asking whether Wegovy does meaningful work without exercise, the clinical evidence says yes.
What exercise changes, though, is worth understanding. Physical activity (even walking) helps preserve lean muscle tissue during weight loss. When weight comes off quickly, some of what the body sheds is muscle alongside fat. Keeping some activity in your week, even gentle movement, shifts that balance. It also supports cardiovascular health and mood, both relevant when you're adjusting to a new treatment. The relationship between Wegovy and exercise is genuinely worth thinking about, even if the gym is not for you.
Not necessarily slower in the early weeks, but probably less over time. The appetite suppression that drives weight loss on semaglutide operates independently of activity level, so the first few months of results tend to look similar across the board. Where the gap opens is at the plateau. Everyone on a weight-loss medicine reaches a point where the body adapts. Adding movement (even modest amounts) shifts that equilibrium.
There is also the question of what you're losing. Studies consistently show that people who combine a GLP-1 medicine with regular activity lose a higher proportion of fat relative to muscle than those who rely on the medicine alone. For most people, muscle matters: it affects strength, metabolic rate, and how you feel day to day. This isn't about punishing yourself with exercise you hate. A consistent 20-minute walk five days a week is genuinely useful. If you want to think through what kind of movement fits your life on treatment, the Wegovy exercise plan guide covers practical, low-barrier options.
One thing that doesn't change based on your activity level: Wegovy is a prescription-only medicine. A GPhC-registered prescriber assesses your suitability before any treatment is dispensed. You can read more about the semaglutide treatment pathway to understand what that assessment covers and why it matters.
This is one of the questions our prescribers hear most often, and it's a fair one. Obesity itself limits mobility for many people. Chronic pain, joint conditions, respiratory problems and fatigue are common, and they're also among the health conditions that make someone eligible for treatment in the first place. If you physically cannot exercise, that does not disqualify you from Wegovy, and it doesn't mean the medicine won't work.
NHS guidance on semaglutide confirms that Wegovy is licensed for weight management alongside a reduced-calorie diet and increased physical activity, the phrase "increased physical activity" is intentionally broad. Starting from almost none and reaching a short daily walk counts. The medicine does the heavy lifting on appetite; movement, at whatever level you can manage, supports the process.
If your mobility is significantly limited, that's exactly the kind of context a prescriber needs to know. It shapes how treatment is monitored and what other support might help. You might also find it useful to read about approaches to weight management beyond medication if you're weighing all your options before committing.
Wegovy can produce clinically significant weight loss without a structured exercise plan. That is not a loophole, it is what the trial evidence shows. But the people who do best tend to combine the medicine with some degree of movement, not because they have to, but because activity protects what they're losing and supports long-term maintenance once the treatment course ends.
If you're physically active and want to understand how to train safely on semaglutide, the guide on exercising on semaglutide covers practical considerations around timing, energy and nausea. If you've been put off by a sense that you need to become a different person to earn the treatment, set that aside. The prescription is for where you are now, not where you imagine you should be.
Cost is a real consideration for many people. What Wegovy costs in the UK depends on the dose and provider; private treatment typically includes the prescription, clinical review and delivery in one figure. At nume, one transparent price covers your consultation, prescription and free next-working-day delivery, no subscription, no hidden charges. If you'd like to understand whether Wegovy is clinically appropriate for your situation, check your eligibility with our prescribers, it starts with a free consultation, reviewed the same day by a real clinician, not automated software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.